In a case where a 64-year-old male presents with PSA 7 and a biopsy shows adenocarcinoma but is uncertain if a DRE was performed, what is the clinical T category?

The correct category for the clinical T classification in this scenario is based on the specifics of the presentation of the adenocarcinoma in the patient. A PSA level of 7 indicates an elevation that could suggest the presence of prostate cancer, and the biopsy confirming adenocarcinoma contributes further to this assessment.

The classification system for prostate cancer (T staging) relies on both clinical examination findings and imaging results. In this case, if a Digital Rectal Examination (DRE) was not performed or its results are uncertain, the staging would typically default to the T category that reflects the minimal clinical information available. The absence of a definitive DRE suggests that there is no evidence of extra-capsular extension or seminal vesicle invasion, which would elevate the T classification to a more advanced category.

Given these considerations, the T1c classification indicates a tumor that is clinically undetectable but is identified through biopsy due to elevated PSA. However, since the question specifically instructs to assess the clinical T category without confirming an external examination, it aligns best with T2, where the tumor is palpable or visible on imaging but confined within the prostate.

Thus, the designation as cT2 implies that despite the uncertainty regarding the DRE, the clinical